# Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA

> **NCT03229122** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 446 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03229122
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-26
- **Primary completion:** 2018-07-06
- **Final completion:** 2018-07-06
- **Target enrollment:** 446 (ESTIMATED)
- **Last updated:** 2019-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03229122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03229122, "Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03229122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*